Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism

Raili Riikonen1, Ismo Makkonen, Raija Vanhala

  • 1Department of Child Neurology, Kuopio University Central Hospital, Kuopio, Finland. raili.riikonen@kolumbus.fi

Insights

Low cerebrospinal fluid insulin-like growth factor-1 (IGF-1) in children with autism may indicate early pathogenesis. This finding suggests IGF-1

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Biochemistry

Background:

  • Cerebral development in autism spectrum disorder (ASD) lacks comprehensive study of key biological regulators.
  • Insulin-like growth factors (IGFs) play crucial roles in neural development and cell survival.

Purpose of the Study:

  • To investigate concentrations of insulin-like growth factors (IGF-1 and IGF-2) in cerebrospinal fluid (CSF) of children with autism.
  • To explore the relationship between CSF IGF levels, age, and head size in children with and without autism.

Main Methods:

  • Radioimmunoassay was used to measure IGF-1 and IGF-2 levels in CSF samples from 25 children with autism and 16 age-matched controls.
  • Statistical analyses were performed to compare IGF concentrations between groups and correlate them with age and head circumference.

Main Results:

  • Children with autism exhibited significantly lower CSF IGF-1 concentrations compared to the control group, particularly those under 5 years old.
  • CSF IGF-1 levels correlated with head circumference in children with autism, but not in controls.
  • No significant difference in CSF IGF-2 concentrations was observed between the two groups.

Conclusions:

  • Reduced early-life CSF IGF-1 may be associated with the pathogenesis of autism, potentially impacting cerebellar Purkinje cell survival.
  • IGF-1 and IGF-2 may influence head growth in children with autism, as reflected by CSF concentrations.

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...